National Jewish Health: all 109 studies

Page 1 of 2. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• MOBoxy: MoblO2 to Maintain OxygenationNot yet recruitingNCT07222592Not applicable
• Effect of Omalizumab in the Skin of Food Allergy PatientsRecruitingNCT06618963Phase 4
• Enhancing Hypnotic Medication Discontinuation in Primary CareRecruitingNCT06435520Phase 4
• Nasal Inflammation Following Endotoxin Challenge in Patients With AsthmaNot yet recruitingNCT06270576Phase 1
• Mycobacteriophage Treatment of Non-tuberculosis MycobacteriaEnrolling by invitationNCT06262282
• Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographYEnrolling by invitationNCT05822102
• Lung Clearance Index to Identify Scleroderma Patients at Risk for ILDRecruitingNCT04535245
• Alveolar Macrophage Programming Following Endotoxin ExposureRecruitingNCT03859050Not applicable
• The Role of Laryngopharyngeal Reflux in IPFRecruitingNCT03418350
• Epigenetic Regulation of Altered T-cell Immunity in SarcoidosisRecruitingNCT03145922
• Deployment-Related Lung Disease Research Database and BiorepositoryRecruitingNCT03035097
• PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic FibrosisEnrolling by invitationNCT02419989
• PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic FibrosisEnrolling by invitationNCT02073409
• Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT01088217
• Sildenafil Exercise: Role of PDE5 InhibitionCompletedNCT04039087Phase 2/3Results posted
• : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)CompletedNCT03445793Results posted
• IV Colistin for Pulmonary Exacerbations: Improving Safety and EfficacyCompletedNCT02918409Phase 4Results posted
• Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CFCompletedNCT02626182Phase 1/2Results posted
• Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)TerminatedNCT02323100Phase 1/2Results posted
• Supplemental Oxygen in Pulmonary FibrosisCompletedNCT01961362Results posted
• The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary SarcoidosisCompletedNCT01587001Not applicableResults posted
• Effects of Sildenafil on CFTR-dependent Ion Transport ActivityCompletedNCT01132482Phase 2Results posted
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNCT01117116Not applicableResults posted
• Targeting Oxidative Stress in Chronic Beryllium DiseaseCompletedNCT01088243Phase 1/2Results posted
• Telecommunication Enhanced Asthma ManagementCompletedNCT00958932Not applicableResults posted
• Progression of Airway Obstruction in Childhood AsthmaCompletedNCT00873873Results posted
• Phase II Study of Digitoxin to Treat Cystic FibrosisCompletedNCT00782288Phase 2Results posted
• Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00659529Phase 1/2Results posted
• COVID-19 Vaccine Response in Chronic Respiratory ConditionsCompletedNCT05313087
• Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction StudyCompletedNCT04942548Not applicable
• A Prognostic Transcriptomic Signature for Chronic Hypersensitivity PneumonitisActive, not recruitingNCT04844359
• Measuring Omalizumab Responses Using Real-world Evidence (MORRE) StudyStatus unknownNCT04724278
• Skin Barrier Abnormalities and Oxidative Stress ResponseStatus unknownNCT04606615
• Saracatinib in the Treatment of Idiopathic Pulmonary FibrosisActive, not recruitingNCT04598919Phase 1/2
• Hand Sanitizer Effects on the Skin BarrierStatus unknownNCT04525521
• Creation of Home-based Asthma Real-World Measures With Mobile Health StudyStatus unknownNCT04462224
• Skin Barrier Assessment in Pregnancy and at BirthStatus unknownNCT04445298
• T Cell Memory Fuels the Innate Response in Chronic CF Lung DiseaseCompletedNCT04397861
• Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic FibrosisCompletedNCT04397809
• Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT04354038
• Observational Trial of the Longitudinal Effects of CFTR Modulator DrugsCompletedNCT04353752
• Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary ExacerbationsCompletedNCT04341532
• Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer ImmunotherapyCompletedNCT04283539
• Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)SuspendedNCT04261582
• Asthma and Intimate Partner ViolenceStatus unknownNCT04216680
• Skin Characteristics of Parents of Food Allergic Pediatric PatientsSuspendedNCT04198753
• Skin Tape Transcriptome Methods in ChildrenCompletedNCT04180644
• Synovial Fluid Biomarkers Pre and Post Hymovis Knee InjectionStatus unknownNCT04093232
• Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema HerpeticumStatus unknownNCT04060550
• Use of Blinded Tapering for Hypnotic DiscontinuationActive, not recruitingNCT04050176Phase 3
• Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.CompletedNCT04038710
• Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic FibrosisCompletedNCT04024423
• Use of DNAse in Neutrophilic AsthmaCompletedNCT03994380Phase 1/2
• Interstitial Lung Disease in Early Rheumatoid ArthritisStatus unknownNCT03977415
• Changing School Start Times: Impact on Student, Family, Teacher, and Community HealthCompletedNCT03964181
• Macrophage Programing in Acute Lung InjuryStatus unknownNCT03844893
• Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusStatus unknownNCT03746197Not applicable
• Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over TimeStatus unknownNCT03616158
• Telehealth Cognitive Behavioral Stress Management for Adults With Cystic FibrosisCompletedNCT03560726Not applicable
• An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo NationActive, not recruitingNCT03377647Not applicable
• Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways DiseaseActive, not recruitingNCT03241420
• Therapist-Directed VS Online Therapy for Insomnia Co-Occuring with Sleep ApneaActive, not recruitingNCT03109210Not applicable
• Evaluating Skin Barrier Dysfunction in Infants at High Risk of AtopyWithdrawnNCT03089476Not applicable
• Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung DiseaseCompletedNCT03012958
• Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyStatus unknownNCT03010436Phase 2
• Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyStatus unknownNCT02947945Phase 2
• The Role of Bacterial Toxins in Human Skin DiseaseStatus unknownNCT02910791
• The Role of Tapering Pace and Selected Traits on Hypnotic DiscontinuationCompletedNCT02831894Phase 2
• The Breathe Well Program for Adults With AsthmaCompletedNCT02761837Not applicable
• Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant AsthmaCompletedNCT02753764Phase 2
• Colorado Marijuana Users Health CohortStatus unknownNCT02735954
• Pneumococcal Post-Vaccination TitersStatus unknownNCT02726347Not applicable
• Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin DeficiencyCompletedNCT02691611
• Identification of Epidermal Signatures in Patients With Atopic DermatitisStatus unknownNCT02680405
• Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)CompletedNCT02604693
• The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)CompletedNCT02596347
• COPDGene/Lung Cancer Center DatabaseCompletedNCT02445183
• Tailored Treatment to Enhance Risk Perception in Sleep ApneaCompletedNCT02314858Not applicable
• Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionTerminatedNCT02220634Not applicable
• Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial HypertensionTerminatedNCT02169752Not applicable
• Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep ApneaCompletedNCT02097212
• The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food AllergyCompletedNCT01950533
• FiteBac Hand Sanitizer in the Management of Hand Dermatitis in AdultsCompletedNCT01950494Not applicable
• Pulmonary Fibrosis Contact RegistryCompletedNCT01935726
• Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine SolutionCompletedNCT01736839
• Lung Cancer Screening Study With Low-dose CT Scan and Blood BiomarkerCompletedNCT01700257Not applicable
• Identification of Molecular Biomarkers to Stratify Patients With Refractory AsthmaCompletedNCT01589198
• Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial HypertensionCompletedNCT01491646
• Dog Hair Extract StudyCompletedNCT01343420Not applicable
• Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01253473Phase 4
• Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 DeviceCompletedNCT01234077Not applicable
• Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT01107028
• Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE LevelsWithdrawnNCT00851370Phase 2
• Markers of Airway Inflammation in BAL Fluid From Children With AsthmaCompletedNCT00838552
• Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART RegimenCompletedNCT00738569Not applicable
• Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel TherapiesCompletedNCT00727285
• Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00700921Phase 2
• Pulmonary Rehabilitation for Idiopathic Pulmonary FibrosisCompletedNCT00692796Not applicable
• Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)CompletedNCT00623246Not applicable
• Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and SarcoidosisCompletedNCT00560989

← National Jewish Health overview and focus areas